Malegra Fxt Plus is a prescription medication used to treat erectile dysfunction and premature ejaculation in adult men. It contains a combination of sildenafil citrate and fluoxetine hydrochloride in a single tablet formulation. The active ingredient sildenafil works by inhibiting phosphodiesterase type five to increase blood flow to the penis. Fluoxetine, a selective serotonin reuptake inhibitor, delays ejaculation by modulating central nervous system neurotransmission. Together the two agents address both vascular insufficiency and neural control to improve sexual performance. The drug is absorbed orally and reaches peak plasma concentrations within one to two hours after ingestion. Its therapeutic effect is maintained for several hours, allowing spontaneous sexual activity without the need for precise timing.

Malegra Fxt Plus is a combined pharmaceutical agent used to address male sexual performance issues. It is prescribed to improve erectile function and to delay ejaculation, thereby enhancing sexual confidence. The drug contains sildenafil which inhibits phosphodiesterase type 5 leading to increased cyclic gmp in penile tissue. This results in smooth muscle relaxation and enhanced blood flow supporting erection. It also contains dapoxetine which acts as a selective serotonin reuptake inhibitor that modulates pathways in the brain involved in ejaculation control. By combining these two active ingredients the formulation simultaneously addresses vascular insufficiency and neural timing factors contributing to sexual dysfunction. The integrated pharmacological activity provides a dual approach that targets both physiological and neurochemical components of male sexual health.

The most common side effects involve mild discomfort rather than serious complications. Headache frequently appears in clinical reports. Nausea and occasional dizziness are also reported. Fatigue may be experienced by some users. Dry mouth occurs occasionally. A mild rash can develop in a small number of cases.

The most common side effects include headache dizziness nausea and fatigue. Patients may also experience dry mouth sore throat and mild rash. These reactions are generally mild and resolve without intervention. Headache often appears early in treatment and tends to improve over time. Dizziness can occur when changing position quickly and usually subsides. Nausea is frequently reported but responds well to simple dietary adjustments. Fatigue may be felt as reduced energy levels during the initial weeks. Sore throat typically manifests as a scratchy sensation and clears within a few days.